Bumper Offer - Urjas oil Just @ Rs. 1
PPG 0.2 Tablet (30) is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Diabetes Type 2.
The correct dosage of PPG 0.2 Tablet (30) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of PPG 0.2 Tablet (30) include Rash, Flatulence, Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of PPG 0.2 Tablet (30) as well, which are listed below. Normally, these side effects of PPG 0.2 Tablet (30) are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, PPG 0.2 Tablet (30)'s effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if PPG 0.2 Tablet (30) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the PPG 0.2 Tablet (30) related warnings section.
PPG 0.2 Tablet (30) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid PPG 0.2 Tablet (30) in conditions like Digestive Disorders, Intestinal Obstruction, Allergy. Other conditions have been mentioned below in the PPG 0.2 Tablet (30) contraindications section.
Drug interactions for PPG 0.2 Tablet (30) have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking PPG 0.2 Tablet (30) is considered safe while driving, and is addictive.
PPG 0.2 Tablet (30) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when PPG 0.2 Tablet (30) is used -
Severe
Mild
Common
Is the use of PPG 0.2 Tablet (30) safe for pregnant women?
PPG has many dangerous side effects in pregnant women. If you are pregnant, do not consume PPG without medical advice.
Is the use of PPG 0.2 Tablet (30) safe during breastfeeding?
PPG should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of PPG 0.2 Tablet (30) on the Kidneys?
PPG rarely affects the kidneys.
What is the effect of PPG 0.2 Tablet (30) on the Liver?
Use of PPG may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of PPG 0.2 Tablet (30) on the Heart?
PPG is rarely harmful for the heart.
PPG 0.2 Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take PPG 0.2 Tablet (30) unless your doctor advises you to do so -
Is this PPG 0.2 Tablet (30) habit forming or addictive?
Forming a habit of PPG 0.2 Tablet (30) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking PPG 0.2 Tablet (30) as it does not make you drowsy.
Is it safe?
Yes, but consume PPG 0.2 Tablet (30) only on doctor's advice.
Is it able to treat mental disorders?
No, PPG 0.2 Tablet (30) is not used to treat mental disorders.
Interaction between Food and PPG 0.2 Tablet (30)
Due to the absence of research, it is difficult to say how PPG 0.2 Tablet (30) and food will interact.
Interaction between Alcohol and PPG 0.2 Tablet (30)
It is difficult to say anything about the effect of PPG 0.2 Tablet (30) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
